Clinical Trial Update: AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating AK112 in combination with chemotherapy as first-line treatment for metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Colorectal Adenocarcinoma | Phase 3 | Status: RECRUITING